Polyarteritis Nodosa

This is a rare disease that causes inflammation in medium-sized arteries. It can affect many parts of the body, like the muscles, joints, and abdomen. The inflammation can damage organs and lead to pain and problems with blood flow.

Condition

What people with Polyarteritis Nodosa report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Polyarteritis Nodosa?

NameHow it went

About Polyarteritis Nodosa

What It Is

Polyarteritis nodosa (PAN) is a rare form of vasculitis, meaning inflammation of blood vessels. In PAN, the immune system attacks the walls of medium-sized arteries, the vessels that carry blood to organs such as the skin, nerves, kidneys, intestines and muscles. Inflamed walls can narrow, close off or weaken into small bulges called aneurysms, so the tissue those arteries feed may not get enough blood. Because many organs can be involved, PAN rarely looks the same in two people. It often builds over weeks or months with fever, night sweats, weight loss and aching muscles and joints. More specific features include painful lumps, ulcers or a net-like purplish pattern on the skin, numbness, tingling or weakness in a hand or foot from damaged nerves, belly pain, and new high blood pressure. In men, pain or swelling in a testicle is a characteristic sign. Some people have PAN confined to the skin (cutaneous PAN), which is managed differently from the whole-body form described here. PAN is also distinct from related conditions it was once grouped with, such as microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis (formerly called Churg-Strauss syndrome).

Causes & Risk Factors

In most people with PAN, no cause is found; this is called idiopathic PAN. It can begin at any age but is most often diagnosed between about 40 and 60, and it is somewhat more common in men. Hepatitis B infection was once a major cause. Vaccination has made hepatitis B-related PAN uncommon in many countries, but it still matters because it is treated differently. Other infections, including hepatitis C and HIV, and some blood and bone marrow disorders, such as myelodysplastic syndrome, can also set off a PAN-like vasculitis. When a cause like this is identified, doctors call it secondary PAN and treat the underlying illness as well. A small number of people have an inherited condition called deficiency of adenosine deaminase 2 (DADA2) that closely mimics PAN and often causes strokes. It frequently begins in childhood, though adults can be affected too. Recognizing it matters because it responds to a different treatment.

How It's Diagnosed

No single blood test confirms PAN. A clinician looks for a pattern of problems across different organs, then works to rule out conditions that can look similar, including infections such as heart valve infection, cancers, clotting disorders and other types of vasculitis. Blood tests usually show raised markers of inflammation, such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and check kidney and liver function. Testing for hepatitis B, hepatitis C and HIV is routine. A test for antineutrophil cytoplasmic antibodies (ANCA) is also important: people with PAN are ANCA negative, so a positive result points toward a related form of vasculitis instead. Urine tests can show blood or protein when arteries in the kidneys are involved. The diagnosis is usually confirmed by a biopsy of an affected area showing inflamed, damaged medium-sized arteries. A deep skin biopsy, taken deep enough to reach those arteries, or a biopsy of an affected nerve together with nearby muscle is most likely to give an answer. When a biopsy is not practical, imaging of the arteries that supply the abdomen, using CT or MRI angiography or a catheter angiogram, can show the typical pattern of aneurysms and narrowing. Nerve conduction studies help identify which nerves are affected. When PAN begins early in life or involves strokes, genetic testing for DADA2 may be added.

Treatment Options

Treatment aims to stop the inflammation quickly, before it permanently damages nerves, kidneys, the gut or other organs, and then to keep the disease quiet with as little medicine as possible. There are no large randomized trials in PAN, so treatment is guided by smaller studies, experience with related types of vasculitis and expert guidelines. Treatment almost always starts with a glucocorticoid (a steroid such as prednisone), which works quickly to calm inflammation and is then gradually tapered. For severe disease that threatens the gut or other vital organs, steroids may begin as high-dose intravenous pulses and are combined with cyclophosphamide, a powerful immune-suppressing drug given by infusion or as tablets. Because of its toxicity, cyclophosphamide is generally limited to about 3 to 6 months and then replaced by a gentler maintenance drug such as azathioprine or methotrexate. For milder disease, US guidelines favor adding azathioprine or methotrexate from the start so steroids can be lowered sooner, although some specialists use steroids alone. The main trade-off is that strong immunosuppression raises the risk of infection, and longer steroid courses can bring weight gain, bone thinning, high blood sugar, raised blood pressure, and mood or sleep changes. Regular blood and urine tests watch for these effects, and preventive antibiotics or bone-protecting measures are sometimes added. After a sustained remission, guidelines suggest stopping the maintenance drug after about 18 months rather than continuing it indefinitely. Other forms are treated differently. Hepatitis B-related PAN combines antiviral medicine with immunosuppression. DADA2 is treated with tumor necrosis factor (TNF) inhibitors, biologic drugs that block an inflammatory signal and help prevent strokes. Physical therapy can help people regain strength and function after nerve or muscle damage.

What to Expect

Untreated, systemic PAN was often fatal, but today most people survive it. In a recent French study of PAN not linked to hepatitis B, nearly 9 in 10 people were alive five years after diagnosis. The outlook is less favorable for people over 65 and for those with kidney injury, gut or brain involvement, or PAN caused by another illness. The first months are usually the most demanding, with frequent appointments, blood tests and dose changes as steroids are reduced. Some people have a single episode that does not return once treatment ends, but long-term studies show relapse is common: reports range from about 1 in 8 to 1 in 3 people with PAN not caused by hepatitis B, and one international study found close to half over about five years. A flare can involve the same organs as before or new ones, and it usually means stepping treatment back up for a time, which is why follow-up continues after medicines stop. Some effects outlast the active disease. Nerve damage can be slow to recover, so neurological exams track progress and physical therapy helps rebuild strength. People who had aneurysms in abdominal arteries may have follow-up imaging to check that they have settled. Living with PAN also means living with its treatment: taking precautions against infection, protecting bones while on steroids, and keeping an eye on weight, blood sugar and blood pressure.

When to Seek Help

See a doctor if unexplained fever, weight loss or muscle and joint pain come together with new numbness or weakness in a hand or foot, painful skin lumps or ulcers, or new high blood pressure, especially if these build over weeks. A rheumatologist, a specialist in immune and inflammatory diseases, usually leads care. If you have PAN, contact your care team promptly about fever or other signs of infection while on immunosuppressive treatment, belly pain that comes on after eating, new numbness or weakness in a limb, or symptoms that return as medicines are reduced. Get emergency care for sudden severe abdominal pain, or for vomiting blood or passing blood in your stool, which can signal bowel damage or internal bleeding. Call 911 for signs of a stroke, such as sudden weakness or numbness on one side of the body, trouble speaking, or a seizure.

Questions to Ask Your Doctor

  1. 1.What type of PAN do I have, and have hepatitis B, DADA2 and other possible causes been checked?
  2. 2.Which organs are involved, and does that make my disease severe or non-severe?
  3. 3.Why are you recommending this combination of medicines, and how long will I likely need each one?
  4. 4.What can I do to lower my infection risk and protect my bones while I am on treatment?
  5. 5.How will we watch for a relapse, and which symptoms should prompt me to call?

Last reviewed • Oct 2026

Educational content, not medical advice.